返回 Agendas
Session Chair(s)
Yutaka Tanaka, PhD
Executive Vice President, Member of the Board
Chugai Pharmaceutical Co., Ltd., Japan
Speaker(s)
The Current Status of Personalized Medicine and the Expectations for the Industry
Toshio Miyata, MD
Health and Global Policy Institute, Japan
Executive Director
Possibility of Personalized Medicine Business Referring the Cases in USA
Eri Himoro
Mizuho Information & Research Institute, Inc., Japan
Consultant
The Challenges and Ideal Model Regarding the Personalized Healthcare Business; From the Viewpoint of Pharmaceutical Company(1)
Shigeru Takeshita, MSc
Astellas Pharma Inc., Japan
Manager, Clinical Pharmacology, Astellas Pharma Global Development
The Challenges and Ideal Model Regarding the Personalized Medicine Business: From the Viewpoint of the Pharmaceutical Company (2)
Shyh-Yuh Liou, PhD
Ono Pharmaceutical Co., Ltd., Japan
Execlusive Advisor, Translational Medicine Center
The Challenges and Ideal Model Regarding the Personalized Medicine Business: From the Viewpoint of the Diagnostics Company
Yoshiaki Tazawa
CHUGAI PHARMACEUTICAL CO., LTD., Japan
Part-time Adviser, Foundation Medicine Business Dept.